I will also say great analysis by Spidey. There were definitely some odd things about CBLI's product. Why did the vehicle animals recover? Why is hardly any data shared about the 48 hour mark? What they did show was not very good, less than 70%. Spidey's contribution of the levels of the three blood lineages was great. CBLI shows statistical significance but not anything meaningful in reality. They still have an advantage of needing only one administration, and I think CBLI will have a future contract as well as PSTI. Their product has real-world applications, but so does ours, and R18 has great results even at 48 hours, which is when more of the masses would likely be receiving their injections rather than 25 hours post radiation. The blood lineage analysis by Spidey was a treasure. PSTI is superior in that regard. Wish we knew the cost of treatment as well as the answers to a few questions. Regardless, I think there is room for both of us. Now if we can get as good of analysis of the treatments from the other 4 companies as provided by Jackie, then we could really analyze our chances of a contract. GLTA!